BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 27.20
-0.20 (-0.73%)
At close: Oct 1, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 159.53 million as of October 1, 2026. Its market cap has decreased by -10.50% in one year.
Market Cap
159.53M
Enterprise Value
112.40M
Revenue
4.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.20
ChartMarket Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 159.53M, a decrease of -23.27%. That is a compound annual growth rate of -14.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 159.53M | 11.80% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.90B |
| Idorsia | 1.23B |
| Basilea Pharmaceutica AG | 841.96M |
| Santhera Pharmaceuticals Holding AG | 232.55M |
| Newron Pharmaceuticals | 173.73M |
| Molecular Partners AG | 127.94M |
| Xlife Sciences AG | 56.52M |
| MindMaze Therapeutics Holding | 24.79M |